Oct 103-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401Canurta Therapeutics is pleased to share that CEO Akeem Gardner participated in the ACT (Accelerating Clinical Trials) Canada Consortium...
May 24Reflecting on the ALS Drug Development Summit in BostonThis week, I had the opportunity to attend the ALS Drug Development Summit in Boston, an event that brought together the brightest minds...